The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...

Following a rough fourth quarter, we see the healthcare sector overall as undervalued, with a median discount to our fair ...

Morgan Stanley slashed its price target on Moderna Inc (BMV:MRNA) (NASDAQ:MRNA) to $38 from $70 given the lowered revenue ...

D.R. Horton should have strong growth prospects with the ongoing U.S. housing shortage. Moderna's pipeline could enable it to return to the winning ways of a few years ago. Pfizer could deliver ...

Loading But Tiba says it needs access to an mRNA manufacturing facility in Australia to make the vaccines at a commercial scale on our shores. The Moderna rejection has forced the company and the ...

In the mRNA vaccine maker’s 2024 Shareholder Letter, CEO Stéphane Bancel reflected upon the company’s second year ...

Moderna shares jumped more than 10% to lead S&P 500 gainers Tuesday, a day after the first bird-flu death was reported in the U.S. The biotech company is developing a vaccine for H5N1. Despite ...

In the latest trading session, Moderna (MRNA) closed at $42.18, marking a +0.43% move from the previous day. This change lagged the S&P 500's 1.26% gain on the day. Elsewhere, the Dow saw an ...

January 26 marks the date the British flag was planted in Port Jackson, or what is now modern Sydney, in 1788, setting in train the development and foundation of modern Australia. ANU historian ...

We recently published a list of 10 Firms End 2024 Stronger With Impressive Gains. In this article, we are going to take a look at where Moderna Inc. (NASDAQ:MRNA) stands against other firms end 2024 ...

These Stocks Moved the Most Today: Super Micro, Moderna, Nvidia, MicroStrategy, Tesla, Palantir, Sangamo, and More Joe Woelfel Tue, December 31, 2024 at 9:16 PM UTC ...

Cue the fireworks because it's now 2025 in some parts of the world. Australia welcomed the new year with a 12-minute fireworks show featuring a golden waterfall effect falling from the iconic ...